β-分泌酶1酶作为前列腺癌的新型治疗点
Hilal A Rather1, Sameh Almousa1, Ashish Kumar1
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Cancers
|January 11, 2024
概括
β-分泌酶1 (BACE1) 与前列腺癌 (PCa) 的进展有关. 用MK-8931抑制BACE1显著降低了PCa细胞增殖和瘤生长,这表明BACE1是高级PCa的新型治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 最近的研究将粉样蛋白前体蛋白 (APP) 和粉样蛋白β (Aβ) 与癌症联系起来.
- β-分泌酶1 (BACE1) 是APP处理中的关键酶,并被认为在致癌过程中发挥作用.
- 在前列腺癌 (PCa) 中准BACE1的治疗潜力在很大程度上仍未被探索.
研究的目的:
- 研究BACE1在前列腺癌 (PCa) 发展和进展中的作用.
- 评估BACE1抑制作为高级PCa治疗策略的疗效.
主要方法:
- BACE1和Aβ1-42表达在人类PCa组织,异种移植和细胞系中使用免疫组织化学 (IHC),实时PCR和PET成像进行了分析.
- 药理学BACE1抑制剂 (MK-8931) 对PCa细胞增殖的影响在体外和体内使用MTT,克隆原和试蓝排除试验进行了评估.
- 进行细胞周期分析和基因表达概况 (前列腺癌特异性途径阵列) 以了解BACE1抑制的机制.
主要成果:
- 在各种PCa模型中检测到BACE1及其下游产物Aβ1-42,证实了BACE1在PCa中的表达和活性.
- 在体外,MK-8931治疗显著抑制了PCa细胞的增殖,并在体内减少了瘤的生长,TRAMP-C1全移植生长减少了81%.
- 抑制BACE1导致细胞循环停止 (增加亚G1种群) 和改变了参与PCa进展的关键基因表达,包括FOXO1.
结论:
- BACE1在前列腺癌中表达和活跃,有助于瘤生长和进展.
- 在临床前的PCa模型中,MK-8931对BACE1的药理抑制显示出显著的抗增殖和抗瘤作用.
- 这些发现确立了BACE1作为晚期前列腺癌的有前途的新型治疗点.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K